SecurityAMPE / Ampio Pharmaceuticals, Inc. (03209T109)
IndustryPharmaceutical Preparations
Institutional Owners82
Institutional Shares18,246,853 - 21.14%
Common Shares Outstanding86,320,968 shares (as of 2018-03-31)
Institutional Value$ 44,044,000 USD

Institutional Stock Ownership and Shareholders()

AMPE / Ampio Pharmaceuticals, Inc. Institutional Ownership

Ampio Pharmaceuticals, Inc. (AMEX:AMPE) has 82 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,246,853 shares. Largest shareholders include Vanguard Group Inc, CVI Investments, Inc., Knoll Capital Management, LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., BlackRock Inc., Millennium Management Llc, Group One Trading, L.p., Geode Capital Management, Llc, and Deutsche Bank Ag\.
Ampio Pharmaceuticals, Inc. (AMEX:AMPE) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/ampe"><img src="https://images.fintel.io/us-ampe-so.png" alt="AMPE / Ampio Pharmaceuticals, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 10,518 36
2018-05-04 13F-HR Trustcore Financial Services, Llc 6,413 22
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 19,722 21,553 9.28 80 73 -8.75
2018-05-03 13F-HR Carnick & Kubik Group, LLC 205,481 205,481 0.00 836 699 -16.39
2018-05-11 13F-HR Tibra Equities Europe Ltd 172,135 585
2018-04-20 13F-HR Pratt Collard Advisory Partners Llc 15,600 15,600 0.00 63 53 -15.87
2018-05-01 13F-HR OPPENHEIMER & CO INC 20,000 23,000 15.00 81 78 -3.70
2018-05-15 13F-HR STATE STREET CORP 26,715 50,915 90.59 109 173 58.72
2018-05-01 13F-HR JJJ Advisors Inc. 16,719 16,719 0.00 68 57 -16.18
2018-04-26 13F-HR JFS WEALTH ADVISORS, LLC 18,150 23,150 27.55 74 79 6.76
2018-05-11 13F-HR CITADEL ADVISORS LLC Call 157,900 537
2018-05-15 13F-HR Nelson, Van Denburg & Campbell Wealth Management Group, LLC 4,500 0 -100.00 18 0 -100.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 13,900 41,600 199.28 57 141 147.37
2018-05-03 13F-HR Cypress Capital Management LLC (WY) 108,400 166,400 53.51 441 566 28.34
2018-05-14 13F-HR Virtu Financial LLC 92,344 0 -100.00 376 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 1,233,284 1,231,987 -0.11 5,019 4,188 -16.56
2018-05-11 13F-HR Cutler Group LP 200 200 0.00 0 0
2018-04-26 13F-HR SIMPLEX TRADING, LLC 147 12,326 8,285.03 0 41
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 115,800 157,900 36.36 471 537 14.01
2017-05-16 13F-HR FIRST FINANCIAL EQUITY CORPORATION 18,220 15
2018-05-15 13F-HR WOLVERINE TRADING, LLC 0 29,615 0 101
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 8,315 27,989 236.61 34 95 179.41
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC Put 106,100 0 -100.00 432 0 -100.00
2018-06-28 13F-HR/A BROWN ADVISORY INC 16,700 0 -100.00 68 0 -100.00
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,505,090 1,505,090 0.00 1,114 1,355 21.63
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 8 20 150.00 0 0
2018-05-11 13F-HR CITIGROUP INC Call 57,700 196
2017-02-10 13F-HR BlackRock Investment Management, LLC 163,225 163,225 0.00 121 147 21.49
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 487,410 487,410 0.00 1,983 1,657 -16.44
2018-04-27 13F-HR COURIER CAPITAL CORP 14,300 14,300 0.00 58 49 -15.52
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 24,000 63,903 166.26 98 217 121.43
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 36,546 0 -100.00 149 0 -100.00
2018-05-15 13F-HR Knoll Capital Management, LP 2,595,484 2,595,484 0.00 10,564 8,825 -16.46
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 0 42,800 0 146
2018-05-15 13F-HR Jefferies Group LLC 38,300 130
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 41,600 141
2018-05-11 13F-HR CITIGROUP INC Put 9,600 33
2018-05-15 13F-HR Verition Fund Management LLC 0 25,809 0 88
2018-05-14 13F-HR Laurion Capital Management LP 70,852 241
2018-05-15 13F-HR Weiss Asset Management LP 38,026 129
2018-05-15 13F-HR LPL Financial LLC 28,200 30,000 6.38 115 102 -11.30
2018-05-09 13F-HR Private Advisor Group, LLC 12,105 28,340 134.12 36 96 166.67
2018-05-11 13F-HR Covington Capital Management 3,200 3,200 0.00 13 11 -15.38
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 47,707 214,183 348.96 194 728 275.26
2018-05-14 13F-HR MORGAN STANLEY 7,254 240,676 3,217.84 30 818 2,626.67
2018-05-15 13F-HR Advisor Group, Inc. 44,901 44,901 0.00 183 153 -16.39
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 64,600 220
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 13,000 14,500 11.54 53 49 -7.55
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 563 0 1
2018-05-01 13F-HR WealthTrust Axiom LLC 10,000 10,000 0.00 40 34 -15.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 228,700 89,000 -61.08 930 303 -67.42
2018-05-07 13F-HR OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 19,508 19,508 0.00 79 66 -16.46
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. Call 20,000 68
2018-05-15 13F-HR BARCLAYS PLC Put 0 80,000 0 272
2018-05-15 13F-HR Cvi Holdings, Llc Put 102,300 348
2018-05-15 13F-HR BRANDES INVESTMENT PARTNERS, LP 50,000 0 -100.00 204 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 121 446,175 368,639.67 0 1,516
2018-05-15 13F-HR VANGUARD GROUP INC 2,313,849 2,915,653 26.01 9,417 9,913 5.27
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 600 600 0.00 2 2 0.00
2018-04-24 13F-HR G&s Capital Llc 2,150 0 -100.00 9 0 -100.00
2017-02-10 SC 13G/A CVI Investments, Inc. 5,000,000 2,877,886 -42.44
2018-05-15 13F-HR ELEMENT CAPITAL MANAGEMENT LLC 0 85,193 0 290
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 33,630 59,084 75.69 137 201 46.72
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 0 2,302 0 8
2018-04-16 13F-HR AMG National Trust Bank 20,000 0 -100.00 81 0 -100.00
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 21,400 46,900 119.16 87 159 82.76
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 20,500 20,500 0.00 83 70 -15.66
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 295,057 39,447 -86.63 1,201 134 -88.84
2018-05-11 13F-HR CITADEL ADVISORS LLC 40,447 138
2018-01-25 13F-HR Concannon Wealth Management, LLC 4,000 0 -100.00 2 0 -100.00
2017-02-10 13F-HR BlackRock Fund Advisors 1,242,644 1,607,641 29.37 920 1,447 57.28
2018-05-09 13F-HR NORTHERN TRUST CORP 140,156 139,992 -0.12 570 476 -16.49
2018-05-04 13F-HR CONDOR CAPITAL MANAGEMENT 21,400 21,400 0.00 87 73 -16.09
2018-05-15 13F-HR JANE STREET GROUP, LLC Call 15,200 52
2018-05-15 13F-HR Bank of New York Mellon Corp 37,916 51,926 36.95 154 176 14.29
2018-05-01 13F-HR Traynor Capital Management, Inc. 14,515 49
2018-04-25 13F-HR GHP Investment Advisors, Inc. 100,000 100,000 0.00 407 340 -16.46
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 18,000 8,000 -55.56 73 27 -63.01
2017-01-13 13F-HR MetLife Securities, Inc 900 900 0.00 1 1 0.00
2018-05-04 13F-HR Trustcore Financial Services, Llc Call 12,000 41
2018-05-11 13F-HR Cutler Group LP Call 400 0 -100.00 0 0
2018-05-11 13F-HR CITIGROUP INC 3,625 100 -97.24 3 0 -100.00
2018-05-09 13F-HR Noven Financial Group, Inc. 158,059 103,964 -34.22 643 353 -45.10
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 40,671 49,921 22.74 166 170 2.41
2018-05-10 13F-HR Wagner Wealth Management, Llc 500 500 0.00 1 2 100.00
2018-05-15 13F-HR ACUTA CAPITAL PARTNERS, LLC Put 325,000 1,105
2018-05-15 13F-HR A.R.T. Advisors, LLC 0 76,093 0 258
2018-05-14 13F-HR Prosight Management, LP 111,150 378
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 185,406 782,407 322.00 755 2,660 252.32
2018-05-02 13F-HR Trellus Management Company, LLC 0 14,413 0 49
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 65,900 85,800 30.20 268 292 8.96
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 468 0 -100.00 2 0 -100.00
2018-05-08 13F-HR COUNTRY TRUST BANK 2,000 2,000 0.00 8 7 -12.50
2018-05-15 13F-HR UBS Group AG 3,700 3,700 0.00 15 13 -13.33
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 0 279,467 0 950
2018-05-15 13F-HR BlueCrest Capital Management Ltd 311,257 1,058
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 175,700 516,200 193.80 715 1,755 145.45
2018-05-03 13F-HR BRIGHTON JONES LLC 30,555 85,555 180.00 124 291 134.68
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 195,100 311,100 59.46 794 1,058 33.25
2018-04-18 13F-HR Creative Planning 28,500 26,000 -8.77 116 88 -24.14
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 45,200 154
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 34,000 43,200 27.06 138 147 6.52
2018-05-11 13F-HR Cutter & CO Brokerage, Inc. 50,000 170
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 10,395 40,447 289.10 42 138 228.57
2018-05-15 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 18,472 20,303 9.91 75 69 -8.00
2018-05-15 13F-HR BARCLAYS PLC 0 30,115 0 102
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 25 25 0.00 102 85 -16.67
2017-02-10 13F-HR BlackRock Advisors LLC 21,025 21,025 0.00 16 19 18.75
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 378 135 -64.29 58 8 -86.21
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 13,659 13,659 0.00 56 46 -17.86

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Warrant You Glad You're Not Long Ampio?

2018-05-15 seekingalpha
Ampio has propped itself up on cash generated through private offerings of discount shares and the exercise of warrants. (6-3)

Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

2018-04-16 seekingalpha
Intercept Pharmaceuticals (ICPT) reported clinical data from a liver biopsy-based substudy from its phase 3 POISE study. The study indicated that long-term OCA treatment in patients with PBC led to reversal or stabilization of fibrosis and cirrhosis. (143-3)

Ampio Pharma's Statements And Actions Are Inconsistent With Its Claimed Partnership Negotiations

2018-03-12 seekingalpha
In Ampio’s conference call on 12/14/17, the CEO euphorically claimed 55 pharma companies are interested, are in negotiations, and that it won’t take long to make a deal. (21-2)

CUSIP: 03209T109